Jenny Revel

Does Fenbendazole Upregulate p53? Yes, Fenbendazole (FenBen) has been reported to upregulate p53, a key tumor suppressor protein, in some cancer models. Mechanism of p53 Upregulation by Fenbendazole: 1.Disruption of Microtubules: •Fenbendazole binds to tubulin, preventing microtubule polymerization in a manner similar to colchicine or vinblastine. •This leads to mitotic arrest, which can trigger cell cycle checkpoints and activation of the p53 pathway. 2.Induction of Cellular Stress & DNA Damage Response: •Microtubule disruption can cause mitotic spindle stress, leading to chromosomal instability. •This activates ATM/ATR kinases, which phosphorylate p53, stabilizing it and increasing its transcriptional activity. 3.Apoptosis and Autophagy Induction: •Upregulated p53 can activate BAX/BAK pro-apoptotic proteins, leading to mitochondrial damage and caspase-dependent apoptosis. •Fenbendazole also promotes autophagy, which can contribute to cancer cell death. 4.Inhibition of Glucose Metabolism (Warburg Effect Reversal): •Some studies suggest Fenbendazole reduces glucose uptake by cancer cells, similar to metformin. •This metabolic stress can further activate AMPK, leading to p53-mediated tumor suppression. Fenbendazole’s Mechanism for Cancer Treatment 1. Microtubule Disruption (Primary Mechanism) •Fenbendazole binds to β-tubulin, disrupting microtubule formation. •This prevents proper mitotic spindle formation, leading to G2/M cell cycle arrest. •Cells stuck in mitotic arrest either undergo apoptosis or senescence. 2. Apoptosis Activation via p53 & BCL-2 Inhibition •Cancer cells often overexpress BCL-2, an anti-apoptotic protein that prevents programmed cell death. •Fenbendazole inhibits BCL-2, shifting the balance towards apoptosis. 3. Disrupting Glucose Metabolism in Cancer Cells •Fenbendazole has been shown to reduce glucose uptake and ATP production, increasing oxidative stress in tumors. •This effect weakens cancer cells that rely on glycolysis (Warburg effect), making them more sensitive to treatment. 4. Synergistic Effects with Chemotherapy & Radiation •Some studies suggest Fenbendazole enhances the effects of radiation and chemotherapy by: •Increasing DNA damage accumulation. •Disrupting repair pathways (e.g., via p53 activation). •Weakening microtubule integrity, making cancer cells more vulnerable to other drugs. Supporting Studies & Evidence 1.Fenbendazole inhibits tumor growth via microtubule disruption and p53 activation •Study in lung cancer cells showed that Fenbendazole caused mitotic arrest, increased p53, and induced apoptosis. •(Source: PubMed) 2.Fenbendazole enhances radiation sensitivity by targeting microtubules and p53 •Research demonstrated that combining Fenbendazole with radiation led to increased DNA damage and cell death. •(Source: PMC) 3.Mechanism of Fenbendazole in disrupting glucose metabolism •Study found Fenbendazole downregulates GLUT1, reducing glucose uptake in cancer cells. •(Source: PubMed) Conclusion Fenbendazole upregulates p53 by causing mitotic stress, DNA damage, and metabolic inhibition, leading to cancer cell apoptosis. Its primary mechanism is microtubule disruption, similar to drugs like Vinblastine or Colchicine, but with lower toxicity. Would you like more detailed references or mechanistic diagrams?